Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endoxifen Efficacy and Safety in Bipolar I Acute Mania
NCT06608641Phase 3Active, not recruiting
- Sponsor
- Jina Pharmaceuticals, Inc.
- Start
- Mar 2024
- Primary completion
- Jun 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of z-endoxifen in bipolar I disorder, sponsored by Jina Pharmaceuticals, Inc.. Started Mar 2024; status: active, not recruiting.
02
Drugs
z-endoxifen
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT06608641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06608641.